Penn State College of Medicine, Department of Family and Community Medicine, Hershey (Drs. Clebak and L. Helm); Penn State College of Medicine, Department of Dermatology (Dr. M. Helm); Maine Medical Center, Department of Dermatology, Portland (Dr. Seiverling). kclebak@pennstatehealth.psu.edu
The authors reported no potential conflict of interest relevant to this article.
Drug-provoked psoriasisis divided into 2 groups: drug-induced and drug-aggravated. Drug-induced psoriasis will improve after discontinuation of the causative drug and tends to occur in patients without a personal or family history of psoriasis. Drug-aggravated psoriasis continues to progress after the discontinuation of the offending drug and is more often seen in patients with a history of psoriasis.14 Drugs that most commonly provoke psoriasis are beta-blockers, lithium, and antimalarials.10 Other potentially aggravating agents include antibiotics, digoxin, and nonsteroidal anti-inflammatory drugs.10
Consider these skin disorders in the differential diagnosis
The diagnosis of psoriasis is usually clinical, and a skin biopsy is rarely needed. However, a range of other skin disorders should be kept in mind when considering the differential diagnosis.
Mycosis fungoides is a type of cutaneous T-cell lymphoma that forms erythematous plaques that may show wrinkling and epidermal atrophy in sun-protected sites. Onset usually occurs among the elderly.
Pityriasis rubra pilaris is characterized by salmon-colored patches that may have small areas of normal skin (“islands of sparing”), hyperkeratotic follicular papules, and hyperkeratosis of the palms and soles.
Seborrheic dermatitis, dandruff of the skin, usually involves the scalp and nasolabial areas and the T-zone of the face.